- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2026
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/34372
| Title: | CASE REPORT: TUBERCULOSIS IN AN INFANT WITH LAMELLAR ICHTHYOSIS |
| Authors: | Romanova, Valeria |
| Keywords: | tuberculosis;infant;lamellar ichthyosis;primary immunodeficiency;BCG vaccination |
| Issue Date: | 2026 |
| Publisher: | Centrul Editorial-Poligrafic Medicina |
| Citation: | Romanova, Valeria. CASE REPORT: TUBERCULOSIS IN AN INFANT WITH LAMELLAR ICHTHYOSIS. In: MedEspera 2026, p. 557. ISBN 978-9975-82-486-6. |
| Abstract: | Introduction. Pediatric tuberculosis (TB) represents an important epidemiological indicator of TB control in the community. According to the WHO Global Tuberculosis Report 2024, children account for approximately 11% of all TB cases worldwide, with an estimated 1.3 million new pediatric cases reported in 2024. Risk factors for active TB in children include genetic susceptibility (inborn errors of immunity), absence of BCG vaccination, immune system immaturity, malnutrition, and co-infections. Effective innate and adaptive immune responses are crucial in controlling Mycobacterium tuberculosis. Primary immunodeficiencies, also referred to as inborn errors of immunity, are heterogeneous genetic disorders affecting immune function. Lamellar ichthyosis is a rare hereditary disorder caused by genetic mutations that impair epidermal barrier formation and regeneration. Case presentation. A 9-month-old boy with antenatally diagnosed lamellar ichthyosis was admitted to the Municipal TB Hospital for Children with clinical signs of infectious intoxication and bronchopulmonary syndrome. He was transferred from a pediatric hospital, where he had been treated for severe bilateral pneumonia refractory to antibacterial therapy. The child was born from the third pregnancy (second delivery); a 15-year-old sibling has the same form of ichthyosis. One previous pregnancy ended in miscarriage at 30-32 weeks. BCG vaccination was contraindicated. The QuantiFERON-TB Gold test was positive, indicating infection with Mycobacterium tuberculosis. Chest computed tomography revealed right mediastinal lymphadenopathy associated with right upper lobe atelectasis. Epidemiological investigation identified close household TB contact. Microbiological confirmation was obtained: GeneXpert MTB/RIF positive (rifampicin-sensitive), smear microscopy positive for acid-fast bacilli, and culture positive on both liquid (BACTEC) and solid (Lowenstein-Jensen) media for Mycobacterium tuberculosis. The child received standard first-line anti-TB therapy for 9 months, resulting in clinical and radiological cure. Discussions. This case underscores the high risk of severe TB in infants with underlying genetic disorders, absence of BCG vaccination, and documented household exposure. The positive QuantiFERON test supported infection and aided diagnostic clarification. Microbiological confirmation allowed timely initiation of appropriate therapy. The case highlights the importance of early TB screening in vulnerable pediatric populations with persistent pneumonia unresponsive to antibiotics. Conclusions. Infants with genetic disorders, unvaccinated with BCG and exposed to TB contacts, represent a high-risk group for active TB. Early microbiological testing and comprehensive evaluation are essential for prompt diagnosis and favorable outcomes. |
| metadata.dc.relation.ispartof: | MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 |
| URI: | https://medespera.md/documents/abstract-book-4.pdf https://repository.usmf.md/handle/20.500.12710/34372 |
| ISBN: | 978-9975-82-486-6 |
| Appears in Collections: | MedEspera 2026
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|